Related Experiment Video
Updated: Jun 21, 2026

08:30
Gene-therapy Inspired Polycation Coating for Protection of DNA Origami Nanostructures
Published on: January 19, 2019
Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery
Noemi Csaba1, Magnus Köping-Höggård, Maria Jose Alonso
1Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.
International Journal of Pharmaceutics
|August 8, 2009
Summary
Ionically crosslinked chitosan (CS) nanoparticles effectively deliver DNA, showing high stability and sustained gene expression in vitro and in vivo. These biocompatible nanoparticles represent a promising non-viral gene delivery system.
Area of Science:
- Biomaterials Science
- Gene Therapy
- Nanotechnology
Background:
- Chitosan (CS) nanoparticles are explored for gene delivery.
- Ionic gelation with pentasodium tripolyphosphate (TPP) is a common formulation method.
- Investigating CS/TPP nanoparticles for DNA delivery is crucial for non-viral gene therapy.
Purpose of the Study:
- To formulate and characterize ionically crosslinked chitosan (CS)/pentasodium tripolyphosphate (TPP) nanoparticles for gene delivery.
- To evaluate their physical-chemical properties, in vitro transfection efficiency, cellular uptake, and in vivo gene expression.
- To assess the impact of co-formulating with bovine serum albumin (BSA).
Main Methods:
- Formulation of CS/TPP nanoparticles using ionic gelation with plasmid DNA or dsDNA oligomers.
- Characterization using TEM, assessment of encapsulation efficiency, physical stability, and DNA release.
- In vitro studies in HEK 293 cells for transfection efficiency and cellular uptake (confocal microscopy).
- In vivo gene expression analysis in mice after intratracheal administration.
Main Results:
- CS/TPP nanoparticles exhibited high encapsulation efficiencies for DNA, independent of CS molecular weight.
- TEM revealed spherical nanoparticles, unlike conventional chitosan polyplexes.
- Low molecular weight (LMW) CS/TPP nanoparticles demonstrated sustained high gene expression in vitro (4-10 days).
- LMW CS/TPP nanoparticles showed strong in vivo beta-galactosidase expression after intratracheal administration.
Conclusions:
- Ionically crosslinked CS/TPP nanoparticles are a stable and effective non-viral gene delivery system.
- LMW CS/TPP nanoparticles offer promising sustained gene expression and in vivo efficacy.
- These nanoparticles provide a foundation for further optimization in gene therapy applications.

